HRAS and skin squamous cell carcinoma: Of note, a model of human cSCC tumorigenesis in a murine xenograft model, involving co-expression of oncogenic HRAS and either cyclin-dependent kinase 4 (CDK4) or the nuclear factor-κB inhibitor IκBα in human keratinocytes, has also been described (154, 155).